| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,412 | 30,129 | 22,429 | 25,317 | | Cost of Revenue | 16,170 | 17,538 | 14,731 | 17,276 | | | Gross Profit | 8,242 | 12,591 | 7,698 | 8,041 | | | Operating Expenses | | Research Development | 2,424 | 3,105 | 3,331 | 3,164 | | Selling General and Administrative | 4,002 | 7,762 | 7,899 | 10,102 | | Non Recurring | 2,804 |
-
| (2,804) | 14,914 | | Others | 250 | 244 | 246 | 356 | | | | Total Operating Expenses | 9,480 |
-
| 8,672 | 28,536 | | | | Operating Income or Loss | (1,238) | 1,480 | (974) | (20,495) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 196 | | Earnings Before Interest And Taxes | (2,241) | 1,480 | (974) | (20,299) | | Interest Expense | (636) | 352 | 284 | 470 | | Income Before Tax | (1,605) | 1,128 | (1,258) | (20,769) | | Income Tax Expense |
-
|
-
|
-
| (574) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,605) | 1,128 | (1,258) | (20,195) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,605) | 1,128 | (1,258) | (20,195) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,605) | $1,128 | ($1,258) | ($20,195) |
|
0.51% Nasdaq 
Income Statement
